2-Propanol,1,3-dibromo- cas no:96-21-9
Synonyms: 1,3-Dibromo-2-hydroxypropane;1,3-Dibromo-2-propanol; 1,3-Dibromohydrin; 1,3-Dibromopropanol;2-Hydroxy-1,3-dibromopropane; Glycerol 1,3-dibromohydrin; Glycerol a,g-dibromohydrin; NSC 636; a,g-Dibromohydrin; a-Dibromohydrin
Name2-Propanol,1,3-dibromo-
CAS96-21-9
Synonyms1,3-Dibromo-2-hydroxypropane;1,3-Dibromo-2-propanol; 1,3-Dibromohydrin; 1,3-Dibromopropanol;2-Hydroxy-1,3-dibromopropane; Glycerol 1,3-dibromohydrin; Glycerol a,g-dibromohydrin; NSC 636; a,g-Dibromohydrin; a-Dibromohydrin
EINECS(EC#)202-489-8
Molecular FormulaC3H6 Br2 O
Molecular Weight217.89
AppearanceAmber liquid.
refractive index1.55-1.554
storage tempRefrigerator
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass3.2
Hazard T:Toxic;Xn:Harmful;
Risk R10;R24/25;R36/37/38;R68
Safety
Poison by intraperitoneal route. Mutation data reported. When heated to decomposition it emits toxic fumes of Br−.
Hazard Note: Harmful
Hazard Codes: 
Xn 
T
Risk Statements about 1,3-Dibromo-2-propanol (CAS No.96-21-9):
R10:Flammable.
R40:Limited evidence of a carcinogenic effect.
R68:Possible risk of irreversible effects.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements about 1,3-Dibromo-2-propanol (CAS No.96-21-9):
S16:Keep away from sources of ignition.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
Attention:
1. Storage: Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
2. Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale.
| 1. |
|
mmo-sat 100 nmol/plate
|
|
ENMUDM Environmental Mutagenesis. 2 (1980),59. |
| 2. |
|
ipr-mus LD50:150 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 17 (1967),145. |
